Villamor, Erlinda N.
HRN: 20-49-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2022
ACICLOVIR 800MG (TAB)
06/13/2022
06/17/2022
PO
800
Q6
Herpes Zoster
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes